Privia Health Group Inc (PRVA)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $3.14B
Last updated: Nov 17, 2026 at 4:20 PM ET
Privia Health Group Inc (PRVA) Stock Chart
Privia Health Group (PRVA) has a latest price of $24.99 on Nov 17, 2026, 13.3% below its 52-week high of $28.82. Its price rose 6.6% over the past 12 months. The month-end price fell 16.4% over the 5 years through Oct 2026, a compound annual decline of 3.5%.
Price Chart
From Apr 2021 to Oct 2026, its highest month-end close was $44.37 in Jun 2021 and its lowest $17.37 in May 2024, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart PRVA with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for PRVA.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 16.3%, and over 6 months it rose 7.3%. The month-end price rose 2.2% over the 3 years through Oct 2026, a compound annual rate of 0.7%.
| Period | Change |
|---|---|
| 1 month | +11.4% |
| 3 months | +16.3% |
| 6 months | +7.3% |
| 12 months | +6.6% |
| 12 months, with dividends | +6.6% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +2.2% | +0.7% |
| 5 years | -16.4% | -3.5% |
Price by Year
Its best calendar year was 2025, when the price rose 21.3%, and its weakest was 2024, when it fell 15.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $21.48 | -9.4% |
| 2025 | $23.71 | +21.3% |
| 2024 | $19.55 | -15.1% |
| 2023 | $23.03 | +1.4% |
| 2022 | $22.71 | -12.2% |
Trading Range
The price is 15.8% above its 50-day average of $21.58 and 10.2% above its 200-day average of $22.69.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $24.99 | |
| 52-week high | $28.82 | -13.3% |
| 52-week low | $18.91 | +32.2% |
| 50-day average | $21.58 | +15.8% |
| 200-day average | $22.69 | +10.2% |
Price Risk
Over 3 years, its largest fall from a peak was 33.6%.
| Measure | Value |
|---|---|
| 1-year beta | 0.29 |
| Largest fall, 1 year | -32.0% |
| Largest fall, 3 years | -33.6% |
Valuation
Privia Health Group traded at 39.5x earnings at the end of 2025, against a 5-year median of 37.7x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About PRVA
What is PRVA's 1-year price change?
Privia Health Group's price rose 6.6% over the past 12 months. With dividends included, the 12-month total return was 6.6%.
What is PRVA's 5-year price change?
Privia Health Group's month-end price fell 16.4% over the 5 years through Oct 2026, a compound annual decline of 3.5%. These figures leave out dividends.
What is PRVA's 52-week high and low?
Privia Health Group's 52-week high is $28.82 and its 52-week low is $18.91. Its latest price of $24.99 on Nov 17, 2026 is 13.3% below the high.
What is PRVA's beta?
Privia Health Group's 1-year beta against the S&P 500 is 0.29, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 32.0%.
Is the PRVA chart free?
Yes. Advanced Charting for PRVA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
PRVA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors